Abstract:Ling-Ling Xu, 1– 4, &ast Yao Yan, 1– 3, &ast Yu-Min Yuan, 1– 3 Ying Li, 1– 3 Jun Jiang, 1– 3 Li-Cai Zhang 1– 3 1 Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University, Xuzhou, People's Republic of China; 2 Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, Xuzhou Medical University, Xuzhou, People's Republic of China; 3 NMPA Key Laboratory for Research and Evaluation of Narcotic and Psychotropic Drugs, Xuzhou, People's Republic of China; 4 Department of Anesthesiology, Nanjing Gaochun People's Hospital, Nanjing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Li-Cai Zhang, Email Objective: To assess the receptors of TRPV1 and GABA B1 receptors that were colocalized in cerebrospinal fluid contacting nucleus (CSF-contact nucleus) of chronic inflammatory pain (CIP) rats bringing inspiration for reducing chronic pain. Methods: A rat model of CIP was constructed by plantar injection of complete Freund's adjuvant (CFA), and the paw withdrawal mechanical threshold (PWMT) and paw withdrawal thermal latency (PWTL) were measured 1, 3, 5, 7, 10, and 14 days after plantar injection. In the first part of the experiment, rats with CIP were divided into the immunofluorescence group and the coimmunoprecipitation (Co-IP) group (n = 6). Rats in the immunofluorescence group were injected with the retrograde tracer CB conjugated with Alexa Fluor 594 into the lateral ventricle two days before the injection of CFA into the plantar surface of the left paw. Three days later, rats that exhibited hyperalgesia were perfused, and their brains were extracted and used for double immunofluorescence staining of the CSF-contacting nucleus. Rats in the Co-IP group were anesthetized and dissected 3 days after CFA injection, and fresh brain segments containing the CSF-contacting nucleus were collected for Co-IP to assess the colocalization of TRPV1 and GABA B1 in the CSF-contacting nucleus (n = 6). In the second part of the experiment, SD rats were divided into the normal saline group (control group) and the CFA group. Fresh CSF-contacting nucleus-containing tissues were collected for Western blot analysis 3 days after plantar injection to observe the changes in TRPV1 and GABA B1 expression in the CSF-contacting nucleus. Results: TRPV1 and GABA B1 were co-expressed in the CSF-contacting nucleus in rats with CIP, and their expression was upregulated. Conclusion: TRPV1 and GABA B1 in the CSF-contacting nucleus are jointly involved in CIP in rats, and there is a direct or indirect link between TRPV1 and GABA B1 . Keywords: cerebrospinal fluid-contacting nucleus, TRPV1 receptor, GABA B1 receptor, chronic inflammatory pain Chronic inflammatory pain (CIP) is pain caused by persistent or unresolved inflammation. Multiple inflammatory stimuli can sensitize nociceptive neurons, thereby promoting pain hypersensitivity. However, animal experiments and clinical practice have shown that inhibition of individual inflammatory pathways is a problematic approach for relieving pain, as parallel signaling cascades can drive pathologic pain and thus promote pain sensitization. 1 It is known that ion channels and receptors in the dorsal root ganglia (DRG) are responsible for the detection of noxious stimuli, and their plasticity contributes to the increased severity of pain. TRP (transient receptor potential) channels are emerging targets for understanding this process and developing novel treatments. Their ability to form multimeric complexes broadens the variety and complexity of channel regulation and the potential implications for pain modulation. 2 Among TRP channels, the capsaicin receptor TRPV1, a non-selective cation channel, is a key molecular component of pain detection and modulation. Sensitization of TRPV1 is central to the initiation of pathological forms of pain, and multiple signaling cascades are known to enhance TRPV1 activity under inflammatory conditions. 3 Hyperalgesia resulting from tissue injury or inflammation is often associated with sensitization of TRPV1 channel activity which can occur through several mechanisms such as phosphorylation, interaction with phospholipid PIP2, trafficking, and association with accessory proteins. 4 The therapeutic glory of TRPV1 is well recognized in clinics which gives a promising insight into the treatment of pain. 5 But the adverse effects associated with some of the antagonists directed the scientists towards other methods. The GABA B receptor is a G pr -Abstract Truncated-

GPR35 agonists inhibit TRPA1-mediated colonic nociception through suppression of substance P release

TRPV4 stimulates colonic afferents through mucosal release of ATP and glutamate

Transient Receptor Potential Ankyrin-1 Participates in Visceral Hyperalgesia Following Experimental Colitis

The pharmacological blockade of P2X4 receptor as a viable approach to manage visceral pain in a rat model of colitis

Attenuation of Colitis-Induced Visceral Hypersensitivity and Pain by Selective Silencing of TRPV1-Expressing Fibers in Rat Colon

GPR39 regulated spinal glycinergic inhibition and mechanical inflammatory pain

GPR151 in Nociceptors Modulates Neuropathic Pain Via Regulating P2X3 Function and Microglial Activation.

Group III mGluR8 negatively modulates TRPA1

Activation of GPR40 Produces Mechanical Antiallodynia Via the Spinal Glial Interleukin-10/Β-endorphin Pathway

P045 MMP12 stimulates colonic afferents, and nociceptors through the activation of PAR1

12--Hydroxyeicosatetraenoic Acid and GPR31 Signaling in Spinal Cord in Neuropathic Pain

TRPV1 and GABAB1 in the Cerebrospinal Fluid-Contacting Nucleus are Jointly Involved in Chronic Inflammatory Pain in Rats

TRPA1 Channel Activation Inhibits Motor Activity in the Mouse Colon

Expression and function of transient receptor potential melastatin 3 in the spinal afferent innervation of the mouse colon

GPR34 in spinal microglia exacerbates neuropathic pain in mice

TRPA1 Agonist-Responsive Afferents Contribute to Central Sensitization by Suppressing Spinal GABAergic Interneurons Through Somatostatin 2A Receptors

Cyclic Analogues of Α‐conotoxin Vc1.1 Inhibit Colonic Nociceptors and Provide Analgesia in a Mouse Model of Chronic Abdominal Pain

GPR30 in spinal cholecystokinin-positive neurons modulates neuropathic pain via mediating descending facilitation

TRPM8 inhibits substance P release from primary sensory neurons via PKA/GSK-3beta to protect colonic epithelium in colitis

Parallel Spinal Pathways for Transmitting Reflexive and Affective Dimensions of Nocifensive Behaviors Evoked by Selective Activation of the Mas-Related G Protein-Coupled Receptor D-Positive and Transient Receptor Potential Vanilloid 1-Positive Subsets of Nociceptors

Activation of GPR55 alleviates neuropathic pain and chronic inflammation